The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
PTEN function: how normal cells control it and tumour cells lose it
Open accessAbstract
The PTEN (phosphatase and tensin homologue deleted on chromosome 10) tumour suppressor is a PI (phosphoinositide) 3-phosphatase that can inhibit cellular proliferation, survival and growth by inactivating PI 3-kinase-dependent signalling. It also suppresses cellular motility through mechanisms that may be partially independent of phosphatase activity. PTEN is one of the most commonly lost tumour suppressors in human cancer, and its deregulation is also implicated in several other diseases. Here we discuss recent developments in our understanding of how the cellular activity of PTEN is regulated, and the closely related question of how this activity is lost in tumours. Cellular PTEN function appears to be regulated by controlling both the expression of the enzyme and also its activity through mechanisms including oxidation and phosphorylation-based control of non-substrate membrane binding. Therefore mutation of PTEN in tumours disrupts not only the catalytic function of PTEN, but also its regulatory aspects. However, although mutation of PTEN is uncommon in many human tumour types, loss of PTEN expression seems to be more frequent. It is currently unclear how these tumours lose PTEN expression in the absence of mutation, and while some data implicate other potential tumour suppressors and oncogenes in this process, this area seems likely to be a key focus of future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
Tamura, M., Gu, J., Matsumoto, K., Aota, S.-I., Parsons, R., & Yamada, K. M. (1998) · Science · doi:10.1126/science.280.5369.1614 · Cited by 1,215
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
Self-citationWang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109
Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,071
Reversible Inactivation of the Tumor Suppressor PTEN by H2O2
Lee, S.-R., Yang, K.-S., Kwon, J., Lee, C., Jeong, W., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111899200 · Cited by 1,057
Crystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946
Regulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers
Mutter, G. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.924 · Cited by 829
Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 818
Sun, H., Lesche, R., Li, D.-M., Liliental, J., Zhang, H., Gao, J., Gavrilova, N., Mueller, B., Liu, X., & Wu, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6199 · Cited by 796
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function
Vazquez, F., Ramaswamy, S., Nakamura, N., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5010-5018.2000 · Cited by 774
Signal-dependent membrane targeting by pleckstrin homology (PH) domains
Lemmon, M. A., & Ferguson, K. M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500001 · Cited by 739
Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils
Xu, J., Wang, F., Van Keymeulen, A., Herzmark, P., Straight, A., Kelly, K., Takuwa, Y., Sugimoto, N., Mitchison, T., & Bourne, H. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00555-5 · Cited by 685
Tumor Suppressor PTEN Mediates Sensing of Chemoattractant Gradients
Iijima, M., & Devreotes, P. (2002) · Cell · doi:10.1016/s0092-8674(02)00745-6 · Cited by 677
McMenamin, M. E., Soung, P., Perera, S., Kaplan, I. D., Loda, M. F., & Sellers, W. R. (1999) · PubMed · Cited by 640
Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., Said, J. W., Isaacs, W. B., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5246 · Cited by 639
The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus
Torres, J., & Pulido, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009134200 · Cited by 629
Redox regulation of PI 3-kinase signalling via inactivation of PTEN
Leslie, N. R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg513 · Cited by 616
Self-citationMutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
Ali, I. U., Schriml, L. M., & Dean, M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1922 · Cited by 542
Phosphoinositide 3-kinase signalling pathways
Cantrell, D. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.8.1439 · Cited by 533
Impaired Fas Response and Autoimmunity in Pten +/− Mice
Cristofano, A. D., Kotsi, P., Peng, Y. F., Cordon-Cardo, C., Elkon, K. B., & Pandolfi, P. P. (1999) · Science · doi:10.1126/science.285.5436.2122 · Cited by 521
Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., & Stokoe, D. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00493-9 · Cited by 477
PTEN and Myotubularin: Novel Phosphoinositide Phosphatases
Maehama, T., Taylor, G. S., & Dixon, J. E. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.247 · Cited by 461
Protean PTEN: Form and Function
Waite, K. A., & Eng, C. (2002) · The American Journal of Human Genetics · doi:10.1086/340026 · Cited by 457
Phosphoinositide 3-kinase signalling pathways
Domin, J. (2006) · Phosphoinositide 3-Kinase Signalling Pathway · doi:10.1142/9781860948091_0003 · Cited by 444
Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten
Gu, J., Tamura, M., Pankov, R., Danen, E. H. J., Takino, T., Matsumoto, K., & Yamada, K. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.2.389 · Cited by 421
PTEN: The down side of PI 3-kinase signalling
Leslie, N. R., & Downes, C. P. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00234-0 · Cited by 415
Self-citationVazquez, F., Grossman, S. R., Takahashi, Y., Rokas, M. V., Nakamura, N., & Sellers, W. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100556200 · Cited by 413
The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network
Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 410
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria, J., Lee, H., Lee, J. I., Luo, W., Issa, J. J., Kemp, B. L., Liu, D. D., Kurie, J. M., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 406
Wu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M. B., Yuan, X.-J., Wood, J., Ross, C., Sawyers, C. L., & Whang, Y. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4233 · Cited by 400
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
Virolle, T., Adamson, E. D., Baron, V., Birle, D., Mercola, D., Mustelin, T., & de Belle, I. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1124 · Cited by 399
Perren, A., Weng, L.-P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L. M., Komminoth, P., Lees, J. A., Mulligan, L. M., Mutter, G. L., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65227-3 · Cited by 378
Directional Sensing Requires Gβγ-Mediated PAK1 and PIXα-Dependent Activation of Cdc42
Li, Z., Hannigan, M., Mo, Z., Liu, B., Lu, W., Wu, Y., Smrcka, A. V., Wu, G., Li, L., Liu, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00559-2 · Cited by 373
Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A., & Macphee, C. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00225-1 · Cited by 365
Self-citationPTEN: from pathology to biology
Sulis, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00175-2 · Cited by 344
Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.7.786 · Cited by 341
Membrane-binding and activation mechanism of PTEN
Das, S., Dixon, J. E., & Cho, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932835100 · Cited by 335
Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN
Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S., & Hall, A. (2004) · Science · doi:10.1126/science.1092089 · Cited by 335
Mutations of the human PTEN gene
Bonneau, D., & Longy, M. (2000) · Human Mutation · doi:10.1002/1098-1004(200008)16:2<109::aid-humu3>3.0.co;2-0 · Cited by 333
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
Kwabi-Addo, B., Giri, D., Schmidt, K., Podsypanina, K., Parsons, R., Greenberg, N., & Ittmann, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201167798 · Cited by 323
Phosphoinositide 3‐kinase‐dependent activation of Rac
Welch, H. C. E., Coadwell, W. J., Stephens, L. R., & Hawkins, P. T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00454-x · Cited by 321
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
Georgescu, M.-M., Kirsch, K. H., Akagi, T., Shishido, T., & Hanafusa, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10182 · Cited by 317
The phosphoinositide (PI) 3-kinase family
Foster, F. M., Traer, C. J., Abraham, S. M., & Fry, M. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00609 · Cited by 305
Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2401-2 · Cited by 302
Structure, function, and biology of SHIP proteins
Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y., & Lucas, D. M. (2000) · Genes & Development · doi:10.1101/gad.14.5.505 · Cited by 294
Salvesen, H. B., MacDonald, N., Ryan, A., Jacobs, I. J., Lynch, E. D., Akslen, L. A., & Das, S. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<22::aid-ijc1002>3.0.co;2-s · Cited by 294
Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer
Depowski, P. L., Rosenthal, S. I., & Ross, J. S. (2001) · Modern Pathology · doi:10.1038/modpathol.3880371 · Cited by 294
Zhou, X.-P., Waite, K. A., Pilarski, R., Hampel, H., Fernandez, M. J., Bos, C., Dasouki, M., Feldman, G. L., Greenberg, L. A., Ivanovich, J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/377109 · Cited by 285
PTEN, a unique tumor suppressor gene.
Dahia, P. L. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070115 · Cited by 283
Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland
Li, G., Robinson, G. W., Lesche, R., Martinez-Diaz, H., Jiang, Z., Rozengurt, N., Wagner, K.-U., Wu, D.-C., Lane, T. F., Liu, X., et al. (2002) · Development · doi:10.1242/dev.129.17.4159 · Cited by 272
Wu, Y., Dowbenko, D., Spencer, S., Laura, R., Lee, J., Gu, Q., & Lasky, L. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909741199 · Cited by 269
(2003) · PubMed · Cited by 269
Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64624-x · Cited by 266
Lu, Y., Yu, Q., Liu, J. H., Zhang, J., Wang, H., Koul, D., McMurray, J. S., Fang, X., Yung, W. K. A., Siminovitch, K. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303621200 · Cited by 261
(1999) · PubMed · Cited by 258
Suppression of PTEN Expression by NF-κB Prevents Apoptosis
Vasudevan, K. M., Gurumurthy, S., & Rangnekar, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1007-1021.2004 · Cited by 246
Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production
Kimura, T., Suzuki, A., Fujita, Y., Yomogida, K., Lomeli, H., Asada, N., Ikeuchi, M., Nagy, A., Mak, T. W., & Nakano, T. (2003) · Development · doi:10.1242/dev.00392 · Cited by 245
A Role for Nuclear PTEN in Neuronal Differentiation
Lachyankar, M. B., Sultana, N., Schonhoff, C. M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P. J., Litofsky, N. S., Recht, L. D., Nabi, R., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01404.2000 · Cited by 230
Direct identification of PTEN phosphorylation sites
Miller, S. J., Lou, D. Y., Seldin, D. C., Lane, W. S., & Neel, B. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03274-x · Cited by 226
The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling
Vazquez, F., & Sellers, W. R. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00032-3 · Cited by 224
Allosteric Activation of PTEN Phosphatase by Phosphatidylinositol 4,5-Bisphosphate
Campbell, R. B., Liu, F., & Ross, A. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300296200 · Cited by 197
Zhou, X.-P., Loukola, A., Salovaara, R., Nystrom-Lahti, M., Peltomäki, P., de la Chapelle, A., Aaltonen, L. A., & Eng, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64200-9 · Cited by 185
Zhou, Y., Tan, F., Hess, K. R., & Yung, W. K. A. (2003) · PubMed · Cited by 185
Byun, D., Cho, K., Ryu, B., Lee, M., Park, J., Chae, K., Kim, H., & Chi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.10962 · Cited by 184
Redox regulation of PTEN and protein tyrosine phosphatases in H2O2‐mediated cell signaling
Cho, S.-H., Lee, C.-H., Ahn, Y., Kim, H., Kim, H., Ahn, C.-Y., Yang, K.-S., & Lee, S.-R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00112-7 · Cited by 184
Pap, T., Franz, J. K., Hummel, K. M., Jeisy, E., Gay, R., & Gay, S. (1999) · Arthritis Research & Therapy · doi:10.1186/ar69 · Cited by 184
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.
Ermoian, R. P., Furniss, C. S., Lamborn, K. R., Basila, D., Berger, M. S., GOTTSCHALK, A. R., Nicholas, M. K., Stokoe, D., & Haas-Kogan, D. A. (2002) · PubMed · Cited by 180
Suzuki, A., Itami, S., Ohishi, M., Hamada, K., Inoue, T., Komazawa, N., Senoo, H., Sasaki, T., Takeda, J., Manabe, M., et al. (2003) · PubMed · Cited by 179
HALVORSEN, O. J., Haukaas, S. A., & Akslen, L. A. (2003) · PubMed · Cited by 175
The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif
Walker, S. M., Leslie, N. R., Perera, N. M., Batty, I. H., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20031839 · Cited by 167
Self-citationWu, W., Wang, X., Zhang, W., Reed, W., Samet, J. M., Whang, Y. E., & Ghio, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303318200 · Cited by 166
The Inositol Phosphatase SHIP Inhibits Akt/PKB Activation in B Cells
Aman, M. J., Lamkin, T. D., Okada, H., Kurosaki, T., & Ravichandran, K. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33922 · Cited by 162
Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han, S., Kato, H., Kato, S., Suzuki, T., Shibata, H., Ishii, S., Shiiba, K.-I., Matsuno, S., Kanamaru, R., & Ishioka, C. (2000) · PubMed · Cited by 158
PTEN mutations are common in sporadic microsatellite stable colorectal cancer
Nassif, N. T., Lobo, G. P., Wu, X., Henderson, C. J., Morrison, C. D., Eng, C., Jalaludin, B. B., & Segelov, E. (2004) · Oncogene · doi:10.1038/sj.onc.1207059 · Cited by 158
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents
Ward, S. G., & Finan, P. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00078-x · Cited by 158
Adey, N. B., Huang, L., Ormonde, P. A., Baumgard, M., Pero, R. S., Byreddy, D. V., Tavtigian, S. V., & Bartel, P. L. (2000) · PubMed · Cited by 158
TPIP: a novel phosphoinositide 3-phosphatase
Walker, S. M., Downes, C. P., & Leslie, N. R. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600277 · Cited by 157
Self-citationPhosphorylation-regulated Cleavage of the Tumor Suppressor PTEN by Caspase-3
Torres, J., Rodriguez, J., Myers, M. P., Valiente, M., Graves, J. D., Tonks, N. K., & Pulido, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212610200 · Cited by 152
Terakawa, N., Kanamori, Y., & Yoshida, S. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100203 · Cited by 151
A Dual Role for Src Homology 2 Domain–Containing Inositol-5-Phosphatase (Ship) in Immunity
Helgason, C. D., Kalberer, C. P., Damen, J. E., Chappel, S. M., Pineault, N., Krystal, G., & Humphries, R. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.781 · Cited by 150
Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383.
Tolkacheva, T., Boddapati, M., Sanfiz, A., Tsuchida, K., Kimmelman, A. C., & Chan, A. M.-L. (2001) · PubMed · Cited by 149
Integrin α4β1 Regulates Migration across Basement Membranes by Lung Fibroblasts
White, E. S., Thannickal, V. J., Carskadon, S. L., Dickie, E. G., Livant, D. L., Markwart, S. M., Toews, G. B., & Arenberg, D. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-041oc · Cited by 145
Targeted disruption of SHIP leads to Steel factor‐induced degranulation of mast cells
Huber, M., Helgason, C. D., Scheid, M. P., Duronio, V., Humphries, R. K., & Krystal, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7311 · Cited by 141
Sarno, S., Moliner, E. D., Ruzzene, M., Pagano, M. A., Battistutta, R., Bain, J., Fabbro, D., Schoepfer, J. G., Elliott, M., Furet, P., et al. (2003) · Biochemical Journal · doi:10.1042/bj20030674 · Cited by 141
PTEN methylation and expression in glioblastomas
Baeza, N., Weller, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0748-4 · Cited by 139
Phosphoinositide-Regulated Kinases and Phosphoinositide Phosphatases
Leslie, N. R., Biondi, R. M., & Alessi, D. R. (2001) · Chemical Reviews · doi:10.1021/cr000091i · Cited by 121
Self-citationMcConnachie, G., Pass, I., Walker, S. M., & Downes, C. P. (2003) · Biochemical Journal · doi:10.1042/bj20021848 · Cited by 117
Self-citationConsiderations When Analyzing the Methylation Status of PTEN Tumor Suppressor Gene
Zysman, M., Chapman, W. B., & Bapat, B. V. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64902-4 · Cited by 110
Synergy in tumor suppression by direct interaction of Neutral Endopeptidase with PTEN
Sumitomo, M., Iwase, A., Zheng, R., Navarro, D., Kaminetzky, D., Shen, R., Georgescu, M., & Nanus, D. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00331-3 · Cited by 109
Accommodating haploinsufficient tumour suppressor genes in Knudson's model
Cook, W. D., & McCaw, B. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203653 · Cited by 105
Tachibana, M., Shibakita, M., Ohno, S., Kinugasa, S., Yoshimura, H., Ueda, S., Fujii, T., Rahman, M. A., Dhar, D. K., & Nagasue, N. (2002) · Cancer · doi:10.1002/cncr.0678 · Cited by 104
Mahimainathan, L., & Choudhury, G. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314328200 · Cited by 103
SKIP Negatively Regulates Insulin-Induced GLUT4 Translocation and Membrane Ruffle Formation
Ijuin, T., & Takenawa, T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1209-1220.2003 · Cited by 102
Déléris, P., Bacqueville, D., Gayral, S., Carrez, L., Salles, J., Perret, B., & Breton, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300816200 · Cited by 102
Acquired somatic mutations in the molecular pathogenesis of COPD
Anderson, G. P., & Bozinovski, S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00052-4 · Cited by 97
Class I phosphoinositide 3-kinases
Anderson, K. E., & Jackson, S. P. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00270-4 · Cited by 93
The TPTE gene family: cellular expression, subcellular localization and alternative splicing
Tapparel, C., Reymond, A., Girardet, C., Guillou, L., Lyle, R., Lamon, C., Hutter, P., & Antonarakis, S. E. (2003) · Gene · doi:10.1016/j.gene.2003.09.038 · Cited by 91
The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases
Backers, K., Bléro, D., Paternotte, N., Zhang, J., & Erneux, C. (2003) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(02)00043-2 · Cited by 85
Dreher, T., Zentgraf, H., Abel, U. R., Kappeler, A., Michel, M., Bleyl, U., & Grobholz, R. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1004-6 · Cited by 82
Hisatake, J., O’Kelly, J., Uskoković, M. R., Tomoyasu, S., & Koeffler, H. P. (2001) · Blood · doi:10.1182/blood.v97.8.2427 · Cited by 81
Leslie, N. R., Alex, G. R. A. Y., Pass, I., Orchiston, E. A., & Downes, C. P. (2000) · Biochemical Journal · doi:10.1042/bj3460827 · Cited by 74
Self-citationWatt, S. A., KIMBER, W. A., Fleming, I. N., Leslie, N. R., Downes, C. P., & Lucocq, J. M. (2004) · Biochemical Journal · doi:10.1042/bj20031397 · Cited by 73
Self-citationInsulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland
Moorehead, R. A., Hojilla, C. V., de Belle, I., Wood, G. A., Fata, J. E., Adamson, E. D., Watson, K. L. M., Edwards, D. R., & Khokha, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306894200 · Cited by 70
Regulation of constitutive expression of mouse PTEN by the 5′-untranslated region
Han, B., Dong, Z., Liu, Y., Chen, Q., Hashimoto, K., & Zhang, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206783 · Cited by 64
Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene
Tolkacheva, T., & Chan, A. M.-L. (2000) · Oncogene · doi:10.1038/sj.onc.1203331 · Cited by 64
Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions
Leslie, N. R., Bennett, D., Alex, G. R. A. Y., Pass, I., Hoang‐Xuan, K., & Downes, C. P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570427 · Cited by 63
Self-citationLipid phosphatases in the regulation of T cell activation: living up to their PTEN‐tial
Seminario, M., & Wange, R. L. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00013.x · Cited by 57
Koul, D., Jasser, S. A., Lu, Y., Davies, M. A., Shen, R., Shi, Y., Mills, G. B., & Yung, W. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205296 · Cited by 55
Caffrey, J. J., Darden, T., Wenk, M. R., & Shears, S. B. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02500-5 · Cited by 47
Genetic interactions between Pten and p53 in radiation-induced lymphoma development
Mao, J., Wu, D., Pérez‐Losada, J., Nagase, H., Delrosario, R., & Balmain, A. (2003) · Oncogene · doi:10.1038/sj.onc.1207083 · Cited by 46
β1-Integrin and PTEN control the phosphorylation of protein kinase C
Parekh, D. B., Katso, R., Leslie, N. R., Downes, C. P., Procyk, K. J., Waterfield, M. D., & Parker, P. J. (2000) · Biochemical Journal · doi:10.1042/bj3520425 · Cited by 44
Self-citationTherapeutic potential of phosphoinositide 3-kinase inhibitors
Drees, B. E., Mills, G. B., Rommel, C., & Prestwich, G. D. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.5.703 · Cited by 42
Rubio, I., & Wetzker, R. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00842-3 · Cited by 37
Tang, X., Wang, L., Proud, C. G., & Downes, C. P. (2003) · Biochemical Journal · doi:10.1042/bj20021910 · Cited by 36
Self-citationPTEN expression is maintained in sporadic colorectal tumours
Taniyama, K., Steve Goodison, B., Ito, R., Bookstein, R., Miyoshi, N., 田原, 榮., Tarin, D., & Urquidi, V. (2001) · The Journal of Pathology · doi:10.1002/path.908 · Cited by 32
Src Homology 2 Domain-containing Inositol 5-Phosphatase 1 Mediates Cell Cycle Arrest by FcγRIIB
Malbec, O., Schmitt, C., Bruhns, P., Krystal, G., Fridman, W. H., & Daëron, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011094200 · Cited by 31
Rubio, I., & Wetzker, R. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00731-4 · Cited by 31
Orchiston, E. A., Bennett, D., Leslie, N. R., Clarke, R. G., Winward, L., Downes, C. P., & Safrany, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310933200 · Cited by 30
Self-citationThe tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover
Maehama, T., Okahara, F., & Kanaho, Y. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320343 · Cited by 26
Cited by
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034
PI3K/AKT signaling pathway and cancer: An updated review
Martini, M., De Santis, M. C., Braccini, L., Gulluni, F., & Hirsch, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912836 · Cited by 1,020
Oncogenic PI3K deregulates transcription and translation
Bader, A. G., Kang, S., Zhao, L., & Vogt, P. K. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1753 · Cited by 798
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
Metadata
- Authors
- LESLIE, N. R., & DOWNES, C. P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2004-08-10
- Volume
- 382
- Issue
- 1
- Pages
- 1-11
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2010784970
- Cited by
- 451
- References
- 134
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.